Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topical ocular drug delivery: recent developments and future challenges.

V H Lee1, J R Robinson

  • 1University of Southern California, School of Pharmacy, Los Angeles.

Journal of Ocular Pharmacology
|January 1, 1986
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure.

Lung cancer (Amsterdam, Netherlands)·2021
Same author

Test-retest reliability of the two-point discrimination test on the sole of the foot in people with multiple sclerosis.

Physiological measurement·2020
Same author

The Avon patellofemoral joint arthroplasty: two- to 18-year results of a large single-centre cohort.

The bone & joint journal·2018
Same author

Neurocardiology.

Handbook of clinical neurology·2017
Same author

Survivorship and clinical outcome of the minimally invasive Uniglide medial fixed bearing, all-polyethylene tibia, unicompartmental knee arthroplasty at a mean follow-up of 7.3years.

The Knee·2016
Same author

Dropped Gallstones Causing a Perihepatic Abscess and Empyema.

Case reports in surgery·2015
Same journal

Systemic delivery of polypeptide drugs through ocular route.

Journal of ocular pharmacology·1994
Same journal

Mucoadhesive ophthalmic vehicles: evaluation of polymeric low-viscosity formulations.

Journal of ocular pharmacology·1994
Same journal

The role of iontophoresis in ocular drug delivery.

Journal of ocular pharmacology·1994
Same journal

Ion exchange resins for ophthalmic delivery.

Journal of ocular pharmacology·1994
Same journal

In situ-forming gels for ophthalmic drug delivery.

Journal of ocular pharmacology·1994
Same journal

A rationale for gene targeting in glaucoma therapy.

Journal of ocular pharmacology·1994
See all related articles

New ocular drug delivery systems offer improved efficiency over primitive methods. This review highlights recent advancements, challenges, and the importance of pharmacokinetic modeling for better eye drug delivery.

Area of Science:

  • Ophthalmology
  • Pharmaceutics
  • Biotechnology

Background:

  • Current topical ocular drug delivery systems are limited in efficiency.
  • The eye presents unique physiological barriers to drug absorption.
  • Advancements in drug delivery technology are needed for improved ocular treatments.

Purpose of the Study:

  • To review recent developments in topical ocular drug delivery systems.
  • To assess their success in overcoming ocular barriers.
  • To identify future challenges and necessary improvements.

Main Methods:

  • Review of recent literature on ocular drug delivery systems.
  • Analysis of pharmacokinetic modeling and bioavailability studies.
  • Evaluation of animal models in ocular drug development.

Related Experiment Videos

Main Results:

  • Recent developments show promise in enhancing ocular drug delivery.
  • Pharmacokinetic modeling and appropriate animal models are crucial for system design.
  • Significant challenges remain, particularly for posterior eye delivery and macromolecular drugs.

Conclusions:

  • The field is poised for rational design of advanced ocular drug delivery systems.
  • Addressing challenges in drug absorption, posterior delivery, and macromolecular transport is essential.
  • Improved non-invasive monitoring and predictive animal models are key future directions.